Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
出版年份 2015 全文链接
标题
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
作者
关键词
Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome, Influenza Vaccine, Narcolepsy, Inflammasome Activation
出版物
DRUG SAFETY
Volume 38, Issue 11, Pages 1059-1074
出版商
Springer Nature
发表日期
2015-10-08
DOI
10.1007/s40264-015-0350-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Does Allergen-specific Immunotherapy Induce Contact Allergy to Aluminium?
- (2016) E Netterlid et al. ACTA DERMATO-VENEREOLOGICA
- Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition
- (2015) Housam Eidi et al. BMC Medicine
- Genetic basis of autoimmunity
- (2015) Alexander Marson et al. JOURNAL OF CLINICAL INVESTIGATION
- MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
- (2015) Beatris Mastelic Gavillet et al. JOURNAL OF IMMUNOLOGY
- Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP–Protein Kinase A and Inflammasome-Dependent IL-1 Signaling
- (2015) Maximilian Larena et al. JOURNAL OF IMMUNOLOGY
- Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
- (2015) Yoshikazu Honda-Okubo et al. VACCINE
- A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
- (2015) Estela Rodriguez-Del Rio et al. VACCINE
- Aluminium in Allergies and Allergen immunotherapy
- (2015) Erika Jensen-Jarolim World Allergy Organization Journal
- Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
- (2014) Brandon Feinen et al. Clinical and Vaccine Immunology
- Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
- (2014) Gerald Aichinger et al. Clinical and Vaccine Immunology
- Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts
- (2014) Calvin C. Willhite et al. CRITICAL REVIEWS IN TOXICOLOGY
- Danger, diversity and priming in innate antiviral immunity
- (2014) Susan E. Collins et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Hypersensitivity Reactions to Vaccine Constituents
- (2014) Jonathan S. Leventhal et al. Dermatitis
- Shortcomings of pertussis vaccines: why we need a third generation vaccine
- (2014) Jan T Poolman Expert Review of Vaccines
- Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?
- (2014) Christopher A Shaw et al. Immunotherapy
- Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin
- (2014) Lorenzo Cosmi et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
- (2014) S. Sohail Ahmed et al. JOURNAL OF AUTOIMMUNITY
- Vaccination-Induced Systemic Autoimmunity in Farmed Atlantic Salmon
- (2014) E. O. Koppang et al. JOURNAL OF IMMUNOLOGY
- Arthritis, a complex connective and synovial joint destructive autoimmune disease: Animal models of arthritis with varied etiopathology and their significance
- (2014) SR Naik et al. Journal of Postgraduate Medicine
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Assessment of benefits and risks in development of targeted therapies for cancer - The view of regulatory authorities
- (2014) Francesco Pignatti et al. Molecular Oncology
- The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells
- (2014) Joseph H. Lorent et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
- (2014) Outi Vaarala et al. PLoS One
- Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case–control study
- (2014) A. Spadea et al. VACCINE
- Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
- (2014) Josianne Nitcheu Tefit et al. VACCINE
- Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- (2014) David Gordon et al. VACCINE
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events
- (2014) Steve Rockman et al. VACCINE
- Aluminium in allergen-specific subcutaneous immunotherapy – A German perspective
- (2014) Matthias F. Kramer et al. VACCINE
- A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection
- (2014) Yoshikazu Honda-Okubo et al. VACCINE
- Ethical considerations in post-market-approval monitoring and regulation of vaccines
- (2014) Alison Thompson et al. VACCINE
- A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
- (2014) Jaap T. van Dissel et al. VACCINE
- Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods
- (2014) Daniela Fanni et al. World Journal of Pediatrics
- Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection
- (2014) Asher Maroof et al. PLoS Pathogens
- Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis
- (2014) Muriel Rigolet et al. Frontiers in Neurology
- Predictive markers of safety and immunogenicity of adjuvanted vaccines
- (2013) Beatris Mastelic et al. BIOLOGICALS
- Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
- (2013) Heriberto Lima Jr. et al. CELL CYCLE
- Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum
- (2013) Olga Vera-Lastra et al. Expert Review of Clinical Immunology
- Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity
- (2013) C. A. Shaw et al. IMMUNOLOGIC RESEARCH
- Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes
- (2013) C.A. Shaw et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Glucosamine Dose/Concentration-Effect Correlation in the Rat with Adjuvant Arthritis
- (2013) Ali Aghazadeh-Habashi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
- (2013) N. Petrovsky et al. JOURNAL OF VIROLOGY
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- A global regulatory science agenda for vaccines
- (2013) Lindsay Elmgren et al. VACCINE
- Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age
- (2013) William L. Heyward et al. VACCINE
- Provider dismissal policies and clustering of vaccine-hesitant families
- (2013) Alison M Buttenheim et al. Human Vaccines & Immunotherapeutics
- Rethinking vaccine policy making in an era of vaccine hesitancy: Time to rebuild, not remodel?
- (2013) Douglas J Opel et al. Human Vaccines & Immunotherapeutics
- How society should respond to the risk of vaccine rejection
- (2013) David Ropeik Human Vaccines & Immunotherapeutics
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine
- (2012) Kae Pusic et al. FASEB JOURNAL
- Oily adjuvants and autoimmunity: now time for reconsideration?
- (2012) M Whitehouse LUPUS
- Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome)
- (2012) O Vera-Lastra et al. LUPUS
- Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
- (2012) Markku Partinen et al. PLoS One
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund’s Adjuvant, and Monophosphoryl Lipid A
- (2012) Juliana Vitoriano-Souza et al. PLoS One
- Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages
- (2012) K. Schroder et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
- (2012) Benjamin P. Sablan et al. VACCINE
- A genomics-based approach to assessment of vaccine safety and immunogenicity in children
- (2012) Olivia J. White et al. VACCINE
- Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo
- (2012) Marina Zaitseva et al. VACCINE
- Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
- (2012) Scott A. Halperin et al. VACCINE
- Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
- (2012) David L. Gordon et al. VACCINE
- Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
- (2012) Yoshikazu Honda-Okubo et al. VACCINE
- Overview of global regulatory toxicology requirements for vaccines and adjuvants
- (2012) Yuansheng Sun et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Carbohydrate-based immune adjuvants
- (2011) Nikolai Petrovsky et al. Expert Review of Vaccines
- Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant
- (2011) Irena Živković et al. Innate Immunity
- Consent and public engagement in an era of expanded childhood immunisation
- (2011) Julie Leask et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
- (2011) James S. McCarthy et al. PLoS One
- Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
- (2011) Theodore F. Tsai et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Pandemic influenza A (H1N1) vaccination in The Netherlands: Parental reasoning underlying child vaccination choices
- (2011) Marloes Bults et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Delta inulin: a novel, immunologically active, stable packing structure comprising -D-[2 -> 1] poly(fructo-furanosyl) -D-glucose polymers
- (2010) P. D. Cooper et al. GLYCOBIOLOGY
- Heat-Labile Enterotoxins as Adjuvants or Anti-Inflammatory Agents
- (2010) Shuang Liang et al. IMMUNOLOGICAL INVESTIGATIONS
- An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
- (2010) M. Lobigs et al. JOURNAL OF GENERAL VIROLOGY
- Flagellin as an Adjuvant: Cellular Mechanisms and Potential
- (2010) S. B. Mizel et al. JOURNAL OF IMMUNOLOGY
- Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults
- (2010) John J. Treanor et al. VACCINE
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- How to win trust over flu
- (2009) NATURE
- Regulators face tough flu-jab choices
- (2009) Declan Butler NATURE
- Parental Refusal of Pertussis Vaccination Is Associated With an Increased Risk of Pertussis Infection in Children
- (2009) J. M. Glanz et al. PEDIATRICS
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
- (2009) David J. M. Lewis et al. PLoS One
- Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants
- (2009) Vishukumar Aimanianda et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Freeing vaccine adjuvants from dangerous immunological dogma
- (2008) Nikolai Petrovsky Expert Review of Vaccines
- CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway
- (2007) Wen Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started